Stockreport

CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks [Yahoo! Finance]

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF Tue, February 18, 2025 at 2:30 PM GMT+1 6 min read In This Article CVM VIENNA, Va., February 18, 2025 BUSINESS WIRE )--CEL-SCI Corporation (NYSE American: CVM) [Read more]